#LetterOpenedTracking#


PRESS RELEASE:
Building Pharma, Biotech and Device Medical Affairs and Sales and Marketing Cultures Featured at the Pharma, Biotech and Device Colloquium, June 6 - 9, 2004, on the Campus of Princeton University
  • Advanced Executive Education on the Interface of Regulation and Business Strategy for Global Pharmaceutical, Biotechnology and Medical Device Enterprises
  • Offering the Following Categories of Continuing Education Credit: AAPC, ACCME, ACMPE, ACPE, AHIMA, ANCC, CA BRN, CISSP/SSCP, CPHIMS, HCCB, MCLE, NASBA
  • June 6 - 9, 2004
  • Classes Held: McCosh Hall, Princeton University
  • Lodging: Forbes College, Princeton University or Nassau Inn, Princeton, NJ
  • www.PharmaColloquium.com
PRESS RELEASE
Contact: Paul Tunnecliff
800-684-4549 phone
registration@hcconferences.com

PRINCETON NJ USA -- HEALTHCARE UPDATE NEWS SERVICETM -- APRIL 14, 2004: The Pharma, Biotech and Device Colloquium, June 6 - 9, 2004, on the campus of Princeton University, www.PharmaColloquium.com, today announced the following special sessions that will be featured at the Colloquium on the afternoon of Monday, June 7, 2004:

BUILDING THE MEDICAL AFFAIRS ORGANIZATION OF THE FUTURE:
  • Eric B. Grossman, MD, FACP, Senior Director, Hypertension, Heart Failure and Diabetes, Pfizer Global Pharmaceuticals, Pfizer Inc., New York, NY
  • Michael Kafrissen, Vice President for Clinical Affairs, Ortho-McNeil Pharmaceutical, a Johnson & Johnson Company, Raritan, NJ
  • Francois Nader, MD, MBA, Senior Vice President, Medical Affairs North America, Aventis Pharmaceuticals, Bridgewater, NJ
  • Mark Wanda, Esq., Vice President, Legal Affairs, Sepracor Inc., Marlborough, MA
  • Michael Conway, Principal, Pharmaceutical and Medical Products Practice, McKinsey & Company, Inc., Florham Park, NJ
DESIGNING THE SALES FORCE OF THE FUTURE: GETTING IT RIGHT:
  • Eric Aaronson, Esq., Corporate Counsel, Pfizer Learning Center, Pfizer Inc., Rye Brook, NY
  • Nancy S. Lurker, Chief Executive Officer and President, ImpactRx, Inc., Mt. Laurel, NJ
  • Jim Salanty, Director of Sales, Lupron, TAP Pharmaceuticals, Inc., Lake Forest, IL
  • David Quigley, Associate Principal, Pharmaceutical and Medical Products Practice, McKinsey & Company, Inc., New York, NY
  • Brian Riewerts, Senior Manager, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP, Baltimore, MD (Moderator)
COLLOQUIUM SPONSORS:
  • AdvaMed
  • Biotechnology Industry Association
  • Harvard Health Policy Review
  • Health Affairs
  • Healthcare Institute of New Jersey
  • National Pharmaceutical Council
  • Pharmaceutical Care Management Association
  • Pharmaceutical Compliance Forum
COLLOQUIUM GRANTORS: KEYNOTE SPEAKERS:

Patricia M. Danzon, Ph.D.
Celia Z. Moh Professor; Professor of Health Care Systems and Insurance and Risk Management, Wharton School, University of Pennsylvania, Author, Pharmaceutical Price Regulation: National Policies vs. Global Interests, Philadelphia, PA

Nancy-Ann DeParle
Senior Advisor, JPMorgan Partners, Former Administrator, Health Care Financing Administration, Washington, DC

Bob Franks
President, Healthcare Institute of New Jersey, Former New Jersey Congressman, Hillside, NJ

Robert S. Galvin, MD, MBA
Director, Global Healthcare, General Electric Company, Founding Member, The Leap Frog Group, Vice Chair, Washington Business Group on Health, Fairfield, CT

Fred Hassan, MBA
Chairman and Chief Executive Officer, Schering-Plough Corporation, Past Chairman, Pharmaceutical Research & Manufacturers of America (PhRMA), Kenilworth, NJ

Pat Kelly
President, US Pharmaceuticals, Vice President, Pfizer Inc., New York, NY

John C. Lechleiter, Ph.D.
Executive Vice President, Pharmaceutical Operations, Eli Lilly and Company, Indianapolis, IN

Peter Leddy
Vice President, Global HR Services, Dell Inc., Round Rock, TX

Mark B. McClellan, MD, PhD
Administrator, Centers for Medicare & Medicaid Services, Washington, DC

Ian Morrison, Ph.D.
Senior Fellow, Institute for the Future, Founding Partner, Harris/Harvard Strategic Health Perspectives, Author, Healthcare in the New Millennium: Vision, Values and Leadership and The Second Curve: Managing the Velocity of Change, Menlo Park, CA

Uwe E. Reinhardt, Ph.D.
James Madison Professor of Political Economy, Woodrow Wilson School, Princeton University, Princeton, NJ

Humphrey Taylor
Chairman, Harris Poll and Harris Interactive, Chairman, National Council on Public Polls, Rochester, NY

The Honorable Tommy Thompson (Invited)
Secretary of Health and Human Services, Department of Health and Human Services, Baltimore, MD

P. Roy Vagelos, MD
Retired Chief Executive Officer and Chairman, Merck & Co., Bedminister, NJ

COLLOQUIUM CO CHAIRS:

Anthony Farino
Partner and Leader, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP, Chicago, IL

John K. Iglehart
Founding Editor, Health Affairs, National Correspondent, New England Journal of Medicine, Washington, DC

Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Past President, Health Care Compliance Association, Founder, International Association of Privacy Professionals, Kenilworth, NJ

Brian Salsberg, JD
Associate Principal, Pharmaceutical and Medical Products Practice, McKinsey & Company, Florham Park, NJ

Karen Williams
President, National Pharmaceutical Council, Reston, VA

SPONSORSHIP INFORMATION:

For sponsorship and advertising information review the Promotional Opportunities pages on the Colloquium website: www.PharmaColloquium.com or contact:

REGISTRATION INFORMATION:

For further registration info, call 800-684-4549, email: registration@hcconferences.com, or write:

    Colloquium Office
    7790 Barberry Ave.
    Yucca Valley, CA USA 92284
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:

For changes or additions, please email your request to: webmaster@PharmaColloquium.com.

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.